Skip to Main Content

Paper Details

Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma.
Proc Natl Acad Sci U S A
75
2018
BET, BET bromodomain, BET protein, BET proteins, BRD2, BRD3, BRD4, BRDT, E2F1, GBM, GBM cells, RNA-Pol2, brain cancers, brain tumor-initiating cells, dBET6, differentiated GBM cells, glioblastoma, permissive
Author NameAffiliation
Benjamin P BermanCenter for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, David Geffen School of Medicine at University of California, Los Angeles (university of california los angeles)
Benjamin P BermanCenter for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, David Geffen School of Medicine at University of California, Los Angeles (university of california los angeles)
James E BradnerDana-Farber Cancer Institute
James E BradnerHarvard Medical School
  • 1 - 4

Datasets

Release 1.2